PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |
| AlphaCentric Advisors LLC | 160,000 | $1,659,200 | 0.94% |
| 683 Capital Management, LLC | 1,100,000 | $11,407,000 | 0.89% |
| Avidity Partners Management LP | 1,617,300 | $16,771,401 | 0.68% |
| Penn Mutual Asset Management, LLC | 62,802 | $651,257 | 0.61% |
| Simplify Asset Management Inc. | 237,935 | $2,467,386 | 0.28% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,061,745 | $11,010,296 | 0.27% |
| EcoR1 Capital, LLC | 700,000 | $7,259,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 1,310,048 | $13,585,198 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 121,892 | $1,264 | 0.11% |
| Woodline Partners LP | 740,021 | $7,674,018 | 0.09% |
External links
This page lists PHATHOM PHARMACEUTICALS INC's shareholders in Q3 2023. To view PHATHOM PHARMACEUTICALS INC's shareholder history, click here.